Back to Search
RYAN SCHIMMER, PHARM.D.
PHARM.D.
Pharmacotherapy Pharmacist
NPI: 1447224662Individual
Specialties, Licenses & Credentials
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
16994(CO)
Research & Publications (20)
Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies.
PMID 12637110·Clin Ther·2003
4-observational
Anesthetic-induced improvement of the inflammatory response to one-lung ventilation.
PMID 19417610·Anesthesiology·2009
2-rct
Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate.
PMID 18644921·Postgrad Med J·2008
8-other
Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate.
PMID 17277001·Ann Rheum Dis·2007
6-review
Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety.
PMID 16522358·Maturitas·2006
6-review
Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis.
PMID 18360577·Ther Clin Risk Manag·2006
8-other
Ropivacaine decreases inflammation in experimental endotoxin-induced lung injury.
PMID 16645448·Anesthesiology·2006
7-preclinical
Inflammatory response of tracheobronchial epithelial cells to endotoxin.
PMID 16100285·Am J Physiol Lung Cell Mol Physiol·2006
7-preclinical
Pulmonary aspiration: new therapeutic approaches in the experimental model.
PMID 16129981·Anesthesiology·2005
7-preclinical
Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis.
PMID 16126016·Bone·2005
3-trial
Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE.
PMID 15811208·Curr Med Res Opin·2005
3-trial
Hypoxia aggravates lipopolysaccharide-induced lung injury.
PMID 15996189·Clin Exp Immunol·2005
7-preclinical
Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury.
PMID 15972102·Respir Res·2005
7-preclinical
Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
PMID 16206354·J Rheumatol·2005
3-trial
A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.
PMID 15563360·Br J Clin Pharmacol·2004
1-meta
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
PMID 15231010·J Bone Miner Res·2004
3-trial
Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.
PMID 15121021·Bone·2004
3-trial
Efficacy and safety of ibandronate given by intravenous injection once every 3 months.
PMID 15121020·Bone·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1055 CLERMONT ST
DENVER, CO 80220 - Phone
- (303) 399-8020
Quick Facts
- NPI
- 1447224662
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile